D

Researcher Profile

Delia Rota-Scalabrini

1

Publications

221

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article The Lancet Oncology Dec 01, 2021

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

Francesca Gay · Pellegrino Musto · Delia Rota-Scalabrini · Luca Bertamini +22 more

10.1016/s1470-2045(21)00535-0 221 citations

Publication Timeline

2021

1

Frequent Co-Authors

Stelvio Ballanti

Mariella Grasso

Pellegrino Musto

Paolo de Fabritiis

Nicola Giuliani